Genome sequencing and cancer

Current Opinion in Genetics and Development

Volumn 22, Issue 3, 2012, Pages 245-250

  Mardis, Elaine R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA METHYLTRANSFERASE 3A; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; SORAFENIB; SULINDAC; SUNITINIB;

3' UNTRANSLATED REGION; ACCURACY; ACUTE GRANULOCYTIC LEUKEMIA; CANCER PROGNOSIS; CANCER REGRESSION; CANCER RELAPSE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CYTOGENETICS; DNA DETERMINATION; DNA SEQUENCE; DNMT3A GENE; DRUG SUBSTITUTION; DRUG TARGETING; DRUG WITHDRAWAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE SEQUENCE; GENE TECHNOLOGY; GENETIC ANALYSIS; HUMAN; IDH1 GENE; IDH2 GENE; LEUKEMOGENESIS; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; PML GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RARALPHA GENE; REVIEW; RNA ANALYSIS; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; TUMOR GENE;

CHROMOSOMES, HUMAN; DISEASE PROGRESSION; DNA, NEOPLASM; GENES, NEOPLASM; GENETIC TESTING; GENOME, HUMAN; GENOMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MUTATION; NEOPLASM METASTASIS; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84862496309     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2012.03.005     Document Type: Review

References (30)

1. Rowley J.D. Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia. Ann Genet 1973, 16:109-112.
2. Rowley J.D., Golomb H.M., Dougherty C. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1977, 1:549-550.
3. Rowley J.D., Golomb H.M., Vardiman J., Fukuhara S., Dougherty C., Potter D. Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia. Int J Cancer 1977, 20:869-872.
4. Golomb H.M., Vardiman J.W., Rowley J.D., Testa J.R., Mintz U. Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). N Engl J Med 1978, 299:613-619.
5. Rowley J.D. The clinical usefulness of chromosome studies in patients with leukemia. Compr Ther 1980, 6:57-64.
6. Rowley J.D. Identification of the constant chromosome regions involved in human hematologic malignant disease. Science 1982, 216:749-751.
7. Mardis E.R. A decade's perspective on DNA sequencing technology. Nature 2011, 470:198-203.
8. Mardis E.R. New strategies and emerging technologies for massively parallel sequencing: applications in medical research. Genome Med 2009, 1:40.
9. Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K., Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008, 456:66-72.
10. Ley T.J., Ding L., Walter M.J., McLellan M.D., Lamprecht T., Larson D.E., Kandoth C., Payton J.E., Baty J., Welch J., et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010, 363:2424-2433.
11. Mardis E.R., Ding L., Dooling D.J., Larson D.E., McLellan M.D., Chen K., Koboldt D.C., Fulton R.S., Delehaunty K.D., McGrath S.D., et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009, 361:1058-1066.
12. Ward P.S., Patel J., Wise D.R., Abdel-Wahab O., Bennett B.D., Coller H.A., Cross J.R., Fantin V.R., Hedvat C.V., Perl A.E., et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010, 17:225-234.
13. Thol F., Damm F., Lüdeking A., Winschel C., Wagner K., Morgan M., Yun H., Göhring G., Schlegelberger B., Hoelzer D., et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol 2011, 29:2889-2896.
14. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615.
15. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
16. Chapman M.A., Lawrence M.S., Keats J.J., Cibulskis K., Sougnez C., Schinzel A.C., Harview C.L., Brunet J.P., Ahmann G.J., Adli M., et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011, 471:467-472.
17. Berger M.F., Lawrence M.S., Demichelis F., Drier Y., Cibulskis K., Sivachenko A.Y., Sboner A., Esgueva R., Pflueger D., Sougnez C., et al. The genomic complexity of primary human prostate cancer. Nature 2011, 470:214-220.
18. Wiegand K.C., Shah S.P., Al-Agha O.M., Zhao Y., Tse K., Zeng T., Senz J., McConechy M.K., Anglesio M.S., Kalloger S.E., et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010, 363:1532-1543.
19. Shah S.P., Köbel M., Senz J., Morin R.D., Clarke B.A., Wiegand K.C., Leung G., Zayed A., Mehl E., Kalloger S.E., et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009, 360:2719-2729.
20. Navin N., Kendall J., Troge J., Andrews P., Rodgers L., McIndoo J., Cook K., Stepansky A., Levy D., Esposito D., et al. Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94.
21. Ding L., Ley T.J., Larson D.E., Miller C.A., Koboldt D.C., Welch J.S., Ritchey J.K., Young M.A., Lamprecht T., McLellan M.D., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012, 481:506-510.
22. Walter M.J., Shen D., Ding L., Shao J., Koboldt D.C., Chen K., Larson D.E., McLellan M.D., Dooling D., Abbott R., et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012, 366:1090-1098.
23. Shah S.P., Morin R.D., Khattra J., Prentice L., Pugh T., Burleigh A., Delaney A., Gelmon K., Guliany R., Senz J., et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813.
24. Ding L., Ellis M.J., Li S., Larson D.E., Chen K., Wallis J.W., Harris C.C., McLellan M.D., Fulton R.S., Fulton L.L., et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010, 464:999-1005.
25. Jones S.J., Laskin J., Li Y.Y., Griffith O.L., An J., Bilenky M., Butterfield Y.S., Cezard T., Chuah E., Corbett R., et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol 2010, 11:R82.
26. Welch J.S., Westervelt P., Ding L., Larson D.E., Klco J.M., Kulkarni S., Wallis J., Chen K., Payton J.E., Fulton R.S., et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA 2011, 305:1577-1584.
27. Grisolano J.L., Wesselschmidt R.L., Pelicci P.G., Ley T.J. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood 1997, 89:376-387.
28. Brown D., Kogan S., Lagasse E., Weissman I., Alcalay M., Pelicci P.G., Atwater S., Bishop J.M. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997, 94:2551-2556.
29. Kelly L.M., Kutok J.L., Williams I.R., Boulton C.L., Amaral S.M., Curley D.P., Ley T.J., Gilliland D.G. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci USA 2002, 99:8283-8288.
30. Wartman L.D., Larson D.E., Xiang Z., Ding L., Chen K., Lin L., Cahan P., Klco J.M., Welch J.S., Li C., et al. Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression. J Clin Invest 2011, 121:1445-1455.